Clinical Trials Browser

Terminated × LSZ102 × Clear all

NCT02734615 2022-08-01

Phase I/Ib Trial of LSZ102 Single Agent or LSZ102 + LEE011 or LSZ102 + BYL719 in ER+ Breast Cancers

Phase 1 Terminated

Advanced or Metastatic ER+ Breast Cancer